News | November 10, 2021
Marksons Pharma PAT slips to Rs 46.28 in Q2FY22
Marksans Pharma has reported consolidated financial results for the period ended September 30, 2021
Marksans Pharma has reported consolidated financial results for the period ended September 30, 2021
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow
Shaan’s hit song `Tanha Dil Tanha Safar relaunched
Ind-Ra continues to expect IPM’s revenue to grow over 12% yoy in FY22
Positive results reinforce the improved efficacy seen with Opdivo-based treatments in four Phase 3 clinical trials in earlier-stage cancers, including lung cancer, bladder cancer, esophageal/gastroesophageal junction cancer and melanoma
In the overall study population through Day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo
Divi's Laboratories Limited has reported consolidated financial results for the period ended September 30, 2021.
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.
Subscribe To Our Newsletter & Stay Updated
